ABNOM
☆ 2022 ۾ جرمني مان Stiftung Warentest نتيجن، ModelDerm سان صارفين جي اطمينان صرف ادا ڪيل ٽيلي ميڊيسن مشوري جي ڀيٽ ۾ ٿورو گهٽ هئي.
References
Q-switched Nd:YAG ليزر اوٽا جي نيويوس ۽ ساڳئي حالتن کي مؤثر طريقي سان علاج ڪرڻ لاء سڃاتل آهي. اسان هڪ مطالعو ڪيو ته اهو ڏسڻ لاءِ ته ڪيئن هڪ high-fluence 1064 nm Q-switched Nd:YAG ليزر غير معمولي علائقن ۾ منگوليا جي جڳهن تي ڪم ڪيو، بغير چمڙي کي روشن ڪرڻ جي. اسان 61 مريضن جو اڀياس ڪيو انهن جڳهن سان، مجموعي طور تي 70 زخمن جو جائزو ورتو. اڌ زخمن جو علاج ليزر سان ڪيو ويو، جڏهن ته ٻين کي مقابلي لاءِ علاج نه ڪيو ويو. اسان نتيجن جو جائزو ورتو هڪ ماپ ۽ هڪ ڊيوائس جنهن کي Mexameter® سڏيو ويندو آهي ميلانين جي سطح کي ماپڻ لاءِ. مريضن جي پيروي ڪئي وئي اوسط 14 مهينن جي علاج گروپ ۾ ۽ 18 مهينن جي مشاهدي گروپ ۾. مطالعي جي آخر ۾، اسان علاج ٿيل ۽ غير علاج ٿيل گروپن جي وچ ۾ پيماني تي سکور ۽ ميلانين جي سطح ۾ اهم فرق ڏٺا، ليزر-علاج ٿيل گروپ سان بهتر نتيجا ڏيکاريندي. High-fluence Q-switched Nd:YAG ليزر، چمڙي جي روشنيءَ جو سبب بڻجڻ کان سواءِ، انهن غير معمولي منگولين جڳهن جي علاج لاءِ اثرائتو ۽ محفوظ ثابت ٿيو.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
اسان ABNOM لاءِ مخصوص ليزر علاج استعمال ڪرڻ جي تاثير ۽ حفاظت جو مطالعو ڪيو، ۽ ڏٺو ته ڪھڙا عنصر اثرانداز ٿي سگھن ٿا ته اھو ڪيئن ڪم ڪري ٿو. اسان 110 مريضن کي ڏٺو جن کي ABNOM هو ۽ ٻن ۽ نون ليزر علاج جي وچ ۾ مليا. اسان اهو محسوس ڪيو ته علاج بهتر ڪم ڪيو اهو ڊگهو ٿي چڪو هو، پر پراڻن مريضن ۾ پڻ نه. اهو پڻ بهتر ڪم ڪيو مريضن ۾ هلڪي چمڙي سان (قسم III) ۽ ننڍا متاثر علائقن (10 cm2 کان گهٽ) . Melasma سان گڏ ABNOM علاج کي گهٽ اثرائتو بڻايو. متاثر ٿيل علائقن جو رنگ يا تعداد ڪو فرق نٿو لڳي. اٽڪل 10 سيڪڙو مريضن کي علاج کان پوءِ اونداهي داغ مليا. شروعاتي ڪيترن ئي علاج سٺو نتيجا ڏنو. اونداهي جلد ۽ اونداهي دڳن وارا پراڻا مريض علاج کان پوءِ وڌيڪ ڪارا داغ حاصل ڪرڻ جا امڪان آهن. ABNOM ۽ melasma سان مريضن لاء، اهو بهتر آهي ته گهٽ توانائي وارو ليزر استعمال ڪيو وڃي ته جيئن melasma کي خراب ڪرڻ کان بچڻ لاء.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
○ علاج
اڇو ڪرڻ وارا ايجنٽ تمام گھٽ مدد ڪن ٿا. melasma جي برعڪس، ABNOM کي ليزر جي علاج سان بهتر ڪري سگهجي ٿو ۽ بغير ٻيهر هٽائڻ لاء ڇڏي وڃي. ABNOM جي علاج لاءِ ليزر علاج 10 کان 20 ڀيرا ڪري سگھجي ٿو.
#QS1064 laser